HomeMy WebLinkAbout10.27.26 Board Correspondence - FW_ (2) UK Knew About Possible Fatal Blood Clot Risk, But Allowed COVID Vaccine Trial on Kids to Continue.ATTENTION: This message originated from outside Butte County. Please exercise judgment before opening
attachments, clicking on links, or replying..
From:Clerk of the Board
To:Mutony, Heather
Cc:Lee, Lewis
Subject:Board Correspondence - FW: (2) UK Knew About Possible Fatal Blood Clot Risk, But Allowed COVID Vaccine Trial
on Kids to Continue
Date:Thursday, October 29, 2026 4:22:38 PM
Attachments:image001.png
Please see Board Correspondence -
Lewis LeeAdministrative Technician - ConfidentialButte County Administration25 County Center Drive, Suite 200 • Oroville, CA 95965T: 530.552.3326www.buttecounty.ca.gov | lelee@buttecounty.ca.gov
From: lance dreiss <lancedreiss@att.net>
Sent: Tuesday, October 27, 2026 9:19 PM
To: Shared Mailbox Clerk of the Board <pcbs@countyofplumas.com>;
Assemblymember.Gallagher@assembly.ca.gov; Senator.Dahle@senate.ca.gov;
danpargee@countyofplumas.com; davidhollister@countyofplumas.com; District Attorney
<District_Attorney@buttecounty.ca.gov>; Nicolereinert@countyofplumas.com; Kitts, Melissa
<mkitts@buttecounty.ca.gov>; Soderstrom, Monica <msoderstrom@buttecounty.ca.gov>; Durfee,
Peter <PDurfee@buttecounty.ca.gov>; Ronald Owens <ronald@muzzledtruth.com>; Kimmelshue,
Tod <TKimmelshue@buttecounty.ca.gov>; Pickett, Andy <APickett@buttecounty.ca.gov>; Connelly,
Bill <BConnelly@buttecounty.ca.gov>; Teeter, Doug <DTeeter@buttecounty.ca.gov>; Beaudoin,
Jarett <JBeaudoin@buttecounty.ca.gov>; Julie Threet <julie4butte5@gmail.com>; Waugh, Melanie
<mwaugh@buttecounty.ca.gov>; Ritter, Tami <TRitter@buttecounty.ca.gov>; Teri DuBose
<Teri.DuBose@mail.house.gov>; Clerk of the Board <clerkoftheboard@buttecounty.ca.gov>;
Stephens, Brad J. <BStephens@buttecounty.ca.gov>
Subject: (2) UK Knew About Possible Fatal Blood Clot Risk, But Allowed COVID Vaccine Trial on Kids
to Continue
Public Record
Children as young as 6 continued receiving AstraZeneca’s COVID-19 vaccine in a 2021
U.K. clinical trial, even though U.K. government advisers were aware of a potentially deadly
blood clot risk, a newly released document reveals. GB News first reported the story Monday.
The revelations arise from the minutes of a May 21, 2021, meeting of the Commission on
Human Medicines, which advises the U.K. government on medicine safety, efficacy and
quality. The meeting addressed a “very small but potentially very serious risk” of vaccine-
induced immune thrombotic thrombocytopenia (VITT).
VITT is a life-threatening syndrome that causes blood clots (thrombosis) and low blood
platelet counts (thrombocytopenia). It has been linked to both mRNA and non-
mRNA COVID-19 vaccines, including the AstraZeneca shot.
The partially redacted document, marked “Official — Sensitive Commercial” and “Not for
Publication,” shows that at least one member at the meeting argued that the trial “should be
allowed to proceed” even though there is often “no successful intervention” available for
VITT.
The minutes revealed that the U.K.’s Paediatric Medicines Expert Advisory Group agreed that
the clinical trial — which enrolled 262 children ages 6-17, including 112 kids ages 6-11 —
should continue, even though the clinical trial was temporarily paused in April 2021 to
investigate reports of “extremely rare” blood clots.
The meeting’s participants — including several advisers with ties to AstraZeneca or Oxford
University, the vaccine’s co-developer — reached this conclusion despite acknowledging that
the vaccine’s “direct benefit” to kids was “quite remote” and that the benefit of vaccination
“when balanced against risk is low.”
https://tdefender.substack.com/p/uk-knew-fatal-blood-clot-risk-astrazeneca-covid-vaccine-
trial-kids
diana dreiss